Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)
Clinical trial NCT04647903 · COMPLETED
Trial details
- NCT number
- NCT04647903
- Sponsor
- Vallon Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2021-12-17
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.